Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning

• Taís Fontoura de Almeida,
• Edézio Ferreira Cunha-Junior,
• João Luiz Mendes Wanderley,
• Juliana da Silva Pacheco,
• Lucia Helena Pinto-da-Silva,
• Valter Viana Andrade-Neto,
• Suzana Passos Chaves

Affiliations

Taís Fontoura de Almeida

Laboratory of Physiopathology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil

Edézio Ferreira Cunha-Junior

Laboratory of Immunoparasitology, Institute of Pharmaceutical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil

João Luiz Mendes Wanderley

Laboratory of Immunoparasitology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil

Juliana da Silva Pacheco

Drug Discovery Unit, Department of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom

Lucia Helena Pinto-da-Silva

Institute of Veterinary, Department of Veterinary Microbiology and Immunology, Seropédica, RJ, Brazil

Valter Viana Andrade-Neto

St Michael Hospital, Li ka Shing Knowledge Institute, Toronto, ON, Canada

Suzana Passos Chaves

Laboratory of Immunoparasitology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil